You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Suppliers and packagers for DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 10MEQ


✉ Email this page to a colleague

« Back to Dashboard


DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 10MEQ

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Baxter Hlthcare DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 10MEQ dextrose; potassium chloride; sodium chloride INJECTABLE;INJECTION 018037 NDA Baxter Healthcare Company 0338-0663-04 1000 mL in 1 BAG (0338-0663-04) 1979-02-02
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: Dextrose 5%, Sodium Chloride 0.2%, and Potassium Chloride 10mEq

Last updated: August 4, 2025


Introduction

The procurement of pharmaceutical formulations such as Dextrose 5%, Sodium Chloride 0.2%, and Potassium Chloride 10mEq requires a detailed understanding of the global supply landscape. These solutions are critical in clinical settings for intravenous therapy, electrolyte repletion, and hydration management. Ensuring access to high-quality suppliers is essential for healthcare providers, manufacturers, and pharmaceutical distributors aiming for compliance, safety, and cost-efficiency. This report delineates key suppliers worldwide, scrutinizes their market positioning, compliance standards, and strategic advantages.


Market Overview

Intravenous electrolyte solutions like Dextrose 5%, Sodium Chloride 0.2%, and KCl 10mEq are classified as sterile, injectable drugs regulated under strict pharmaceutical manufacturing standards. The suppliers in this market range from multinational pharmaceutical companies to regional and specialized contract manufacturing organizations (CMOs). Suppliers must adhere to Good Manufacturing Practices (GMP), quality assurance protocols, and regulatory approvals from authorities such as the FDA (U.S. Food and Drug Administration), EMA (European Medicines Agency), or other regional agencies.


Major Global Suppliers

1. Baxter International Inc.

Overview: Baxter is a leading global provider of sterile injectable solutions, including electrolyte mixtures. Their extensive product portfolio and robust distribution network make them a go-to source for hospitals and pharmaceutical companies.

Product Range: Baxter supplies Dextrose, Sodium Chloride, and KCl solutions in various concentrations, conforming to international standards (USP, EP, JP).

Strengths: Recognized for high-quality manufacturing, compliance with global regulatory standards, and innovative delivery systems such as prefilled syringes and infusion bags.

Regulatory Standing: Baxter is approved by the FDA and EMA, with certifications covering GMP compliance and ISO standards.

2. B. Braun Melsungen AG

Overview: A German healthcare company specializing in infusion therapy and clinical nutrition. B. Braun offers a wide range of intravenous solutions, including Dextrose and Electrolyte solutions.

Product Range: B. Braun supplies sterile Dextrose 5%, Sodium Chloride 0.2%, and KCl 10mEq solutions that meet pharmacopeial specifications.

Strengths: Noted for innovation in infusion therapy and sustained supply stability, especially in European markets.

Regulatory Standing: Certified by EMA, with compliance to GMP and ISO standards.

3. Fresenius Kabi

Overview: A global healthcare company known for injectable pharmaceuticals and clinical nutrition solutions. Fresenius Kabi manufactures electrolyte solutions both for hospital use and bulk supply.

Product Range: Their offerings include Dextrose 5%, sodium chloride, and potassium chloride infusion solutions conforming to pharmacopoeial specifications.

Strengths: Extensive manufacturing facilities, established quality control protocols, and strong regional presence.

Regulatory Standing: Approved by agencies such as the FDA, EMA, and local health authorities, with rigorous GMP adherence.

4. Hospira (a Pfizer company)

Overview: Hospira specializes in sterile medications and infusion devices, including electrolyte solutions.

Product Range: Their electrolytes follow strict standards, with formulations similar to those specified.

Strengths: High reliability, extensive product catalogue, and global distribution network.

Regulatory Standing: Fully compliant with FDA regulations and GMP standards.

5. Local and Regional Suppliers

Numerous regional manufacturers, especially in India, China, and Eastern Europe, produce Dextrose and electrolyte solutions. Notable examples include:

  • Safeway Medical (India): Provides cost-effective electrolyte solutions compliant with Indian Pharmacopoeia (IP) and WHO standards.
  • Shandong Weigao Group (China): Supplies infusion solutions including Dextrose and electrolytes, meeting Chinese pharmacopeial standards and export requirements.

While these local suppliers can be cost-effective, their compliance status and international certifications must be thoroughly verified.


Criteria for Supplier Selection

When sourcing Dextrose 5%, Sodium Chloride 0.2%, and KCl 10mEq, consider the following factors:

  • Regulatory approval: Confirm manufacturing licenses, GMP certification, and product registration with relevant authorities.
  • Quality assurance: Suppliers must have rigorous testing protocols, stability data, and batch consistency.
  • Supply stability: Evaluate manufacturing capacity, inventory management, and the supplier's history of supply continuity.
  • Cost competitiveness: Balance quality and compliance with budget constraints, especially in large-volume procurement.
  • Regional compliance: Ensure products meet regional pharmacopeias (USP, EP, JP, IP) depending on market location.

Emerging Trends and Considerations

  • Manufacturing Consolidation: Larger pharmaceutical companies continue consolidating to ensure supply chain integrity, impacting market dynamics.
  • Regulatory Stringency: Increasing regulatory scrutiny emphasizes supplier compliance with GMP and international standards.
  • Customization & Innovative Delivery: Suppliers investing in prefilled infusion bags and ready-to-use solutions enhance patient safety and operational efficiency.
  • Regional Market Growth: Asian suppliers are expanding their global footprints through capacity upgrades and quality certifications.

Challenges in the Supply Chain

  • Supply Disruptions: Due to geopolitical factors, pandemics, or raw material shortages, maintaining supply continuity remains complex.
  • Regulatory Divergences: Variations in regional standards necessitate dual certifications or local approvals.
  • Price Fluctuations: Raw material prices, especially for glucose and salts, impact manufacturing costs.

Conclusion

The supply landscape for Dextrose 5%, Sodium Chloride 0.2%, and Potassium Chloride 10mEq is globally diverse, with established multinational corporations offering high-quality, certified products and regional suppliers providing cost-effective alternatives. Strategic sourcing should prioritize compliance, supply stability, and regulatory alignment suited to the intended market. As the industry evolves, maintaining relationships with approved, reliable suppliers is pivotal for healthcare institutions and pharmaceutical manufacturers to ensure uninterrupted, safe, and compliant intravenous solutions.


Key Takeaways

  • Major global suppliers include Baxter, B. Braun, Fresenius Kabi, and Hospira, offering reliable, GMP-compliant electrolyte solutions.
  • Regional manufacturers in Asia, particularly India and China, can be viable sources, provided they meet international quality standards.
  • Supplier selection should focus on regulatory compliance, quality assurance, supply stability, and cost-effectiveness.
  • Supply chain resilience is crucial; diversification of suppliers mitigates risks of disruptions.
  • Regulatory and market trends favor suppliers with GMP certifications, innovative delivery systems, and regional compliance.

FAQs

1. How can I verify the compliance and quality standards of electrolyte solution suppliers?
Verify certifications such as GMP, ISO, and product registration with relevant authorities like the FDA, EMA, or regional agencies. Request COA (Certificate of Analysis) and batch testing reports.

2. Are regional manufacturers capable of meeting international quality standards for electrolyte solutions?
Many regional manufacturers attain certifications such as ISO and adhere to GMP standards, but due diligence is required to confirm compliance with specific pharmacopeial requirements relevant to your market.

3. What are the main factors influencing the cost of electrolyte solutions?
Raw material costs, manufacturing scale, regulatory compliance expenses, certification requirements, and regional labor costs significantly impact product pricing.

4. How important is regional regulation compliance for electrolyte solutions?
It is critical, as products must meet local pharmacopeial standards (USP, EP, JP, IP), and local approvals ensure legal access and market acceptance.

5. Can I rely solely on a single supplier for vital electrolyte solutions?
Relying on a single supplier poses supply chain risks. Diversifying sources and establishing agreements with multiple certified suppliers enhances supply security.


References

[1] Baxter International. Product information and certifications.
[2] B. Braun. Infusion solutions product portfolio.
[3] Fresenius Kabi. Quality and compliance data.
[4] Hospira. Regulatory status and manufacturing standards.
[5] Indian Pharmacopoeia Commission. Guidelines for pharmaceutical manufacturing in India.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.